-
SYSTEMATIC LITERATURE REVIEW AND CRITICAL APPRAISAL OF COST-EFFECTIVENESS MODELS OF ANTIMICROBIAL TREATMENTS
Aug 11, 2026, 17:16 PM -
WHY TWO BRANDS FOR ONE MOLECULE? STRATEGIC IMPLICATIONS OF DUAL-BRAND APPROACHES FOR ORPHAN DESIGNATIONS, REVENUE THRESHOLDS AND PRICING IN GERMANY
Aug 11, 2026, 17:16 PM -
LONGITUDINAL TRENDS IN MORTALITY AGE AMONG PATIENTS WITH SICKLE CELL DISEASE: REAL-WORD DATA (2013-2024)
Aug 11, 2026, 17:16 PM -
HOW CAN WE APPROACH WHOLE HEALTH USING DIGITAL BIOMARKERS AND ENDPOINTS FROM CONSUMER WEARABLES?
Aug 11, 2026, 17:16 PM -
INCLUSION OF CAREGIVER QUALITY-OF-LIFE IN ECONOMIC EVALUATIONS: GLOBAL HTA PERSPECTIVES AND IMPACT
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS OF FLURBIPROFEN VERSUS LOXOPROFEN SODIUM CATAPLASMS IN KNEE OSTEOARTHRITIS: EVIDENCE FROM A PHYSICIAN-PHARMACIST COLLABORATIVE RANDOMIZED TRIAL
Aug 11, 2026, 17:16 PM -
PROVISIONAL AND TIME-LIMITED ACCESS PATHWAYS - A COMPARATIVE ANALYSIS OF CANADA, UK, EU, AND AUSTRALIA
Aug 11, 2026, 17:16 PM -
IMPACT OF SURGICAL TIMING AND PRE-INCISION ANTIBIOTICS ON MATERNAL AND NEONATAL OUTCOMES IN EMERGENCY CESAREAN SECTIONS: A PROSPECTIVE STUDY
Aug 11, 2026, 17:16 PM -
OBSTRUCTIVE SLEEP APNEA, PHYSICAL ACTIVITY, AND RISK OF INCIDENT CHRONIC KIDNEY DISEASE: A PROSPECTIVE COHORT STUDY FROM THE UK BIOBANK
Aug 11, 2026, 17:16 PM -
A DISCRETE EVENT SIMULATION MODEL FOR THE HEALTH ECONOMIC EVALUATION OF A RAPID AI-GUIDED WHOLE-GENOME SEQUENCING PLATFORM FOR THE DIAGNOSIS OF ESKAPEE BLOODSTREAM INFECTIONS: MODEL DEVELOPMENT AND METHODOLOGY
Aug 11, 2026, 17:16 PM -
AGREEMENT BETWEEN ARTIFICIAL INTELLIGENCE AND HUMAN ASSESSMENT IN QUALITY APPRAISAL OF ECONOMIC EVALUATIONS USING THE DRUMMOND CHECKLIST
Aug 11, 2026, 17:16 PM -
TRAJECTORIES AND COMPOSITION OF COSTS ACROSS DISEASE PROGRESSION STAGES IN DUCHENNE MUSCULAR DYSTROPHY: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
CHARACTERISTICS AND TREATMENT PATTERNS OF A REAL-WORLD COHORT OF PATIENTS WITH ADVANCED HER2-MUTANT NSCLC: INSIGHTS FROM THE ESME DATABASE
Aug 11, 2026, 17:16 PM -
THE BEST OF BOTH WORLDS? HYBRID PROGRAMMATIC-AI WORKFLOWS FOR HTA-GRADE EVIDENCE GENERATION FOR TIME-TO-EVENT ANALYSIS INTERPRETATION AND REPORTING
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF PEMBROLIZUMAB AS FIRST-LINE TREATMENT FOR METASTATIC NON-SMALL CELL LUNG CANCER WITH HIGH PD-L1 EXPRESSION IN SAUDI ARABIA
Aug 11, 2026, 17:16 PM -
AUTOMATED QUALITY ASSURANCE FOR LLM-ASSISTED EVIDENCE EXTRACTION IN SYSTEMATIC REVIEWS
Aug 11, 2026, 17:16 PM -
FASTER, MOSTLY FAITHFUL: CAN AI REPRODUCE MANUAL PICO EXTRACTION IN PREPARATION FOR EU JCA?
Aug 11, 2026, 17:16 PM -
DEVELOPMENT AND CONTENT VALIDATION OF THE FIRST CARETAKER-REPORTED GENERIC HEALTH-RELATED QUALITY OF LIFE (HRQL) INSTRUMENT FOR HORSES
Aug 11, 2026, 17:16 PM -
ONE CONCEPT, MANY COHORTS: IMPACT OF COHORT PHENOTYPE DEFINITIONAL VARIANCE IN DEPRESSION, MAJOR DEPRESSIVE DISORDER AND TREATMENT-RESISTANT DEPRESSION ON REAL-WORLD RESEARCH
Aug 11, 2026, 17:16 PM -
SHORT- AND MID-TERM OUTCOMES OF TEVAR IN DESCENDING THORACIC AORTIC PATHOLOGIES: INSIGHTS FROM A FRENCH NATIONWIDE COHORT
Aug 11, 2026, 17:16 PM
